Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Rhythm Biosciences Ltd. ( (AU:RHY) ) has provided an update.
Rhythm Biosciences Ltd. has announced an update concerning the acquisition of Genetype, a leading portfolio of personalized disease risk tests. The announcement highlights the potential impact on the company’s operations, implying a strategic expansion within the personalized healthcare market. However, the presentation contains disclaimers regarding the accuracy and completeness of the information, and the outcomes remain uncertain due to ongoing investigations and research.
More about Rhythm Biosciences Ltd.
YTD Price Performance: -1.15%
Average Trading Volume: 332,765
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$24.95M
For a thorough assessment of RHY stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue